glp-1 and alzheimer's Receptor Agonists in Neurodegeneration: Neurovascular Unit in the Spotlight Prevention of Dementia with GLP-1

But as enthusiasm surges among recreational athletes and biohackers alike, experts warn that the science has yet to catch up with the hype and that the biggest risks may not be the ones people expect Walk into almost any gym today and youll hear conversations that would have seemed out of place just a few years ago

Ben Greenfield: Yeah, I remember that

I want to welcome Mary Watanabe, the Director of the Department of Managed Healthcare, who's joined by Sara Ream, Chief Counsel at DMHC

[2,3] Depression has been represented as the first ten leading causes of disability-adjusted life-years in the adult population (1050 years) that imposes psychological, occupational, educational, and economic costs on the patient and societies